E-Book | March 21, 2025

Life Sciences Companies Talk Past, Present, And Future At JPM

Source: Citeline
GettyImages-2024513353 drug manufacturing

The 43rd annual J.P. Morgan Healthcare Conference (JPM) featured presentations from a host of large, medium, and small-cap life sciences companies that discussed past performance and future outlooks. Highlights include GSK’s plan to launch five new drugs in 2025 and Merck’s strategy for combating Keytruda’s loss of exclusivity in 2028.

access the E-Book!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Citeline